Skip to main content

Uremic Toxins and Organ Failure

  • Book
  • © 2020

Overview

  • Provides detailed descriptions of toxico-pathological mechanisms

  • Presents the latest research on the gut-kidney axis

  • Describes a new therapeutic strategy for CKD

  • Includes special chapters in indoxyl sulfate, ADMA, Sulfotransferase 1A1, and D-serine

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (11 chapters)

Keywords

About this book

This book describes the latest research on the gut-kidney axis of ureic solutes; the toxico-pathological mechanisms of uremic toxin-induced organ failure, including kidney and cardiovascular tissue; and the preventive therapeutic strategies for uremia and related organ failure associated with kidney injuries and diseases. Retained uremic toxins cause a variety of symptoms, such as hypertension, fatigue, renal anemia, osteoporosis and neurologic impairment, which are apparent in chronic kidney disease (CKD) patients. The human gastrointestinal tract contains trillions of microorganisms, referred to as gut microbiota, which support the host metabolism by producing nutrients, such as vitamins and short-chain fatty acids. However, they also produce various harmful uremic toxins that show renal and cardiovascular toxicity, and correlate with an increased mortality in CKD patients. The composition and balance of gut microbiota are associated with the accumulation of uremic toxins and the pathophysiology of CKD, and as such are being considered for a novel therapeutic strategy.

Editors and Affiliations

  • Department of Pharmacy, Kumamoto University Hospital, Kumamoto University, Kumamoto, Japan

    Hideyuki Saito

  • Division of Nephrology, Endocrinology, and Vascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan

    Takaaki Abe

About the editors

Hideyuki Saito

Department of Pharmacy, Kumamoto University Hospital & Department of Clinical Pharmaceutical Sciences, Kumamoto University Graduate School of Life Sciences, Kumamoto University

Honjo, Chuo-ku, Kumamoto, Japan

Email: saitohide@kuh.kumamoto-u.ac.jp

 

Takaaki Abe

Division of Nephrology, Endocrinology, and Vascular Medicine, Department of Medicine

Tohoku University Graduate School of Medicine

Seiryo-cho, Aoba-ku, Sendai, Japan

Email: takaabe@med.tohoku.ac.jp


Bibliographic Information

  • Book Title: Uremic Toxins and Organ Failure

  • Editors: Hideyuki Saito, Takaaki Abe

  • DOI: https://doi.org/10.1007/978-981-15-7793-2

  • Publisher: Springer Singapore

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: Springer Nature Singapore Pte Ltd. 2020

  • Hardcover ISBN: 978-981-15-7792-5Published: 13 October 2020

  • Softcover ISBN: 978-981-15-7795-6Published: 14 October 2021

  • eBook ISBN: 978-981-15-7793-2Published: 12 October 2020

  • Edition Number: 1

  • Number of Pages: VIII, 180

  • Number of Illustrations: 17 b/w illustrations, 22 illustrations in colour

  • Topics: Nephrology, Gastroenterology, Cardiology

Publish with us